Explore the Global AI-Assisted Clinical Trial Protocol Design Market — analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036.

Future Market Insights

AI-Assisted Clinical Trial Protocol Design Market

Key Insight

AI-assisted clinical trial protocol design sales will strengthen through 2036, anchored by protocol feasibility and optimization tools at 32.0% share in 2026. Phase II and Phase III trials hold 49.0% share while sponsor-facing SaaS platforms hold 52.0%. The market reaches USD 5,110.0 million by 2036 from USD 640.0 million.

May 11, 2026

Anurag Sharma

250 Pages

Cite this Report

AI-Assisted Clinical Trial Protocol Design Market

https://www.futuremarketinsights.com/reports/ai-assisted-clinical-trial-protocol-design-market

License

Buy Now

Summary ToC Infographics Companies

Key Players

Clario
ConcertAI
IQVIA
Lokavant
Medidata
Owkin
Saama
Tempus Group
TriNetX
Unlearn

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

AI-Assisted Clinical Trial Protocol Design Market

Key Players

Similar Industry Reports